David DeLucia | executive |
Thane Wettig | executive |
Deyaa Adib | executive |
Juan Graham | executive |
Dalton Greenwood | analyst |
Dina Ramadane | analyst |
Kyuwon Choi | analyst |
Chris Chung | executive |
Good day, and welcome to the FibroGen Second Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to David DeLucia, VP of Investor Relations. Please go ahead.
Good afternoon, everyone. Thank you for joining today to discuss our second quarter 2024 financial and business results.